Susan E. Dorman

Medical University of South Carolina — United States

Medicine · Health Sciences

58h-index12.9kcitations213works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(167), Mycobacterium research and diagnosis(95), Infectious Diseases and Tuberculosis(49), Pneumocystis jirovecii pneumonia detection and treatment(39), Pneumonia and Respiratory Infections(38)

Publications209 total

P-1989. Utility of Karius Testing in High-Risk Immunocompromised Hosts: A Retrospective Study
Open Forum Infectious Diseases·2026Open Access
P-194. Feasibility and effectiveness of standard World Health Organization-recommended treatment in a community setting for Buruli ulcer in Togo: a prospective pilot study
Open Forum Infectious Diseases·2026Open Access
P-1756. Utility and Clinical Impact of Karius Testing in the Adult Population of a Tertiary Care Center: A Retrospective Study
Open Forum Infectious Diseases·2026Open Access
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020
Emerging infectious diseases·2025Open Access
Diagnostic accuracy of the Cepheid MTB host response assay for the detection of pulmonary TB
IJTLD OPEN·2025Open Access
PERFORMANCE OF FUJILAM VERSION 1 FOR THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN UNDER 5 YEARS IN UGANDA – A BRIEF REPORT
2025Open Access
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development
The Lancet Infectious Diseases·2025
Diagnostic accuracy of a commercial AI digital stethoscope for diagnosis of TB
IJTLD OPEN·2025· 1 citedOpen Access
Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol
BMC Pediatrics·2025· 2 citedOpen Access
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis
Trials·2025· 2 citedOpen Access
Preferences for Tongue Swab versus Sputum Collection for Tuberculosis Testing: A Multi-Country Survey
2025· 2 citedOpen Access
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis
The Lancet Global Health·2025· 2 citedOpen Access
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis
Clinical Infectious Diseases·2025Open Access
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Nature Communications·2025Open Access
Prominence of Mycobacterium tuberculosis biomarkers among sputum culture-negative clinic attendees, independent of Ultra status
Journal of Infection and Public Health·2025· 1 citedOpen Access
Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND Cohort
Open Forum Infectious Diseases·2025· 3 citedOpen Access
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
2025Open Access
Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative review
Respiratory Medicine·2025Open Access
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Emerging infectious diseases·2025· 1 citedOpen Access
Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis
PLoS Medicine·2025· 5 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Steven M. Holland(12), Richard E. Chaisson(11), David Alland(7), Derek T. Armstrong(7), Jerrold J. Ellner(7), Maunank Shah(7), Andrew Vernon(6), Moses Joloba(6), William R. Bishai(6), Payam Nahid(5), Kelly E. Dooley(5), Timothy R. Sterling(5), Lydia Nakiyingi(4), Mark P. Nicol(4), Yukari C. Manabe(4), Stefan Goldberg(4), John L. Johnson(4), Neil Martinson(4), Marc Weiner(4), Charles M. Heilig(4)